Hepatitis Lab Follow-Up in Kathmandu — Monitoring The Two-Step Completion, the Treatment Follow-Up & the Ongoing Monitoring

Hepatitis Follow-Up — the Monitoring Layer

Hepatitis follow-up is monitoring layer after detection — the HCV completing two-step ( anti-HCV positive → the RNA for active-vs-cleared → the DAA where active → the SVR12 at 12 weeks confirming cure); the HBV staged monitoring ( carrier state assessed — active vs inactive — viral load and liver function monitored ~3–6 months).

The follow-up is part single test misses: anti-HCV alone does not distinguish active from cleared (the RNA is completion); treated HCV needs the SVR12 confirmation ( cure confirmed); the HBV carrier needs staged monitoring ( active-vs-inactive determining management).

The honest framing: hepatitis is chronic-managed or curable-managed — follow-up being monitoring layer that produces complete management, not just detection.

The HCV Follow-Up — the Two-Step Completed

The HCV follow-up completes two-step: anti-HCV positive → the RNA ( active-vs-cleared — virus present or gone) → where active the DAA regimen (~8–12 weeks — curative) → the SVR12 ( sustained viral response at 12 weeks — cure confirmation).

The follow-up is part single anti-HCV misses — the RNA determining whether curative applies, the SVR12 confirming cure — complete pathway detection-to-cure requires.

The HBV Follow-Up — the Staged Monitoring

The HBV follow-up is staged monitoring — the HBsAg positive is assessed for chronic-carriage picture (the HBeAg, viral load, liver function — active vs inactive carrier distinguished) — management by stage ( monitoring for inactive, suppression for active).

The monitoring is ongoing care — the ~3–6 month viral load and liver function — carrier state tracked, flare or progression caught, management adjusted by stage.

The SVR12 — the Cure Confirmed

The SVR12 is cure confirmation — sustained viral response at 12 weeks post-treatment — undetectable RNA at the 12-week point being the "cured" determination for the HCV.

The SVR12 is follow-up that confirms treatment worked — the ~95%+ cure rate confirmed by sustained viral response — definitive outcome check after the DAA.

The Ongoing Monitoring — the Managed Chronic

The ongoing monitoring is managed-chronic layer — the HBV carrier monitored ~3–6 months ( viral load, liver function, stage — flare or progression caught), liver assessed where chronic produced damage ( fibrosis, cirrhosis — the LFT plus imaging where warranted).

The honest framing: hepatitis is managed (the HBV — suppression or monitoring) or curable (the HCV — the DAA plus the SVR12 confirmation) — follow-up being complete management, not test-and-done.

Hepatitis Follow-Up & Costs

Transparent pricing; confirm when booking.

Related Services & Guides